Screening for Prostate Cancer: Controversy? What Controversy?

Overview

Journal Curr Oncol

Publisher MDPI

Specialty Oncology

Date 2009 Jun 16

PMID 19526077

Citations 6

Authors

R J Ablin

M R Haythorn

Affiliations

Soon will be listed here.

Citing Articles

Screening for prostate cancer in a city in Japan: age-specific prostate-specific antigen cutoff thresholds.

Terao H, Nagasaka H, Yamamoto S, Suzuki A, Usui K, Nakaigawa N Cancer Causes Control. 2023; 35(4):671-677.

PMID: 38012421 DOI: 10.1007/s10552-023-01824-6.

Screening for prostate cancer: protocol for updating multiple systematic reviews to inform a Canadian Task Force on Preventive Health Care guideline update.

Bennett A, Beck A, Shaver N, Grad R, LeBlanc A, Limburg H Syst Rev. 2022; 11(1):230.

PMID: 36289518 PMC: 9609189. DOI: 10.1186/s13643-022-02099-9.

Assessment of factors associated with PSA level in prostate cancer cases and controls from three geographical regions.

Karunasinghe N, Minas T, Bao B, Lee A, Wang A, Zhu S Sci Rep. 2022; 12(1):55.

PMID: 34997089 PMC: 8742081. DOI: 10.1038/s41598-021-04116-8.

Vibrational spectroscopy of liquid biopsies for prostate cancer diagnosis.

Medipally D, Cullen D, Untereiner V, Sockalingum G, Maguire A, Nguyen T Ther Adv Med Oncol. 2020; 12:1758835920918499.

PMID: 32821294 PMC: 7412923. DOI: 10.1177/1758835920918499.

The role of interpersonal relationships in men's attendance in primary care: qualitative findings in a cohort of men with prostate cancer.

Forbat L, Place M, Hubbard G, Leung H, Kelly D Support Care Cancer. 2013; 22(2):409-15.

PMID: 24197054 DOI: 10.1007/s00520-013-1989-y.

References

Andriole G, Crawford E, Grubb 3rd R, Buys S, Chia D, Church T . Mortality results from a randomized prostate-cancer screening trial. N Engl J Med. 2009; 360(13):1310-9. PMC: 2944770. DOI: 10.1056/NEJMoa0810696. View

de Koning H, Blom J, Merkelbach J, Raaijmakers R, Verhaegen H, van Vliet P . Determining the cause of death in randomized screening trial(s) for prostate cancer. BJU Int. 2004; 92 Suppl 2:71-8. DOI: 10.1111/j.1465-5101.2003.04402.x. View

Welch H, Schwartz L, Woloshin S . Prostate-specific antigen levels in the United States: implications of various definitions for abnormal. J Natl Cancer Inst. 2005; 97(15):1132-7. DOI: 10.1093/jnci/dji205. View

Beaulac J, Fry R, Onysko J . Lifetime and recent prostate specific antigen (PSA) screening of men for prostate cancer in Canada. Can J Public Health. 2006; 97(3):171-6. PMC: 6976087. View

Ablin R, SOANES W, Bronson P, Witebsky E . Precipitating antigens of the normal human prostate. J Reprod Fertil. 1970; 22(3):573-4. DOI: 10.1530/jrf.0.0220573. View